Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Jacobson

Showing results (561-570 of 602) with videos related to

Pageof 61
Sort By:
Molecular Neurodegeneration|September 5, 2015
A novel BACE inhibitor NB-360 shows a superior pharmacological profile and robust reduction of amyloid-β and neuroinflammation in APP transgenic miceUlf Neumann, Heinrich Rueeger, Rainer Machauer, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|June 24, 2011
The second-generation active Aβ immunotherapy CAD106 reduces amyloid accumulation in APP transgenic mice while minimizing potential side effectsChristoph Wiessner, Karl-Heinz Wiederhold, Alain C Tissot, et al.
Clinical Journal of the American Society of Nephrology : CJASN|December 18, 2014
Recent changes in therapeutic approaches and association with outcomes among patients with secondary hyperparathyroidism on chronic hemodialysis: the DOPPS studyFrancesca Tentori, Mia Wang, Brian A Bieber, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|May 16, 2009
Prescription of antihypertensive agents to haemodialysis patients: time trends and associations with patient characteristics, country and survival in the DOPPSAntonio Alberto Lopes, Jennifer L Bragg-Gresham, Sylvia P B Ramirez, et al.
Neurobiology of Aging|July 28, 2016
Longitudinal noninvasive magnetic resonance imaging of brain microhemorrhages in BACE inhibitor-treated APP transgenic miceNicolau Beckmann, Arno Doelemeyer, Stefan Zurbruegg, et al.
Clinical Kidney Journal|April 14, 2025
Increasing the adoption of home dialysis through improved advanced kidney care patient education: a call for actionUlrika Hahn Lundström, Gert Meeus, Tommy Aronsen, et al.
Diabetes Care|August 23, 2012
Hemoglobin A(1c) levels and mortality in the diabetic hemodialysis population: findings from the Dialysis Outcomes and Practice Patterns Study (DOPPS)Sylvia Paz B Ramirez, Keith P McCullough, Jyothi R Thumma, et al.
British Journal of Pharmacology|August 9, 2023
Orexin 2 receptor antagonism sex-dependently improves sleep/wakefulness and cognitive performance in tau transgenic miceRyan J Keenan, Heather Daykin, Jeremy Metha, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|August 28, 2018
Missed Hemodialysis Treatments: International Variation, Predictors, and Outcomes in the Dialysis Outcomes and Practice Patterns Study (DOPPS)Issa Al Salmi, Maria Larkina, Mia Wang, et al.
Research Square|February 27, 2026
Historic drought shifted fishing from a stigmatized practice and food to an adaptive livelihood among Daasanach pastoralists in northern KenyaKedir Teji Roba, Alfredo J Rojas, Matthew J Douglass, et al.
Pageof 61

Showing results (561-570 of 602) with videos related to

Sort By:
Pageof 61
Molecular Neurodegeneration|September 5, 2015
A novel BACE inhibitor NB-360 shows a superior pharmacological profile and robust reduction of amyloid-β and neuroinflammation in APP transgenic miceUlf Neumann, Heinrich Rueeger, Rainer Machauer, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|June 24, 2011
The second-generation active Aβ immunotherapy CAD106 reduces amyloid accumulation in APP transgenic mice while minimizing potential side effectsChristoph Wiessner, Karl-Heinz Wiederhold, Alain C Tissot, et al.
Clinical Journal of the American Society of Nephrology : CJASN|December 18, 2014
Recent changes in therapeutic approaches and association with outcomes among patients with secondary hyperparathyroidism on chronic hemodialysis: the DOPPS studyFrancesca Tentori, Mia Wang, Brian A Bieber, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|May 16, 2009
Prescription of antihypertensive agents to haemodialysis patients: time trends and associations with patient characteristics, country and survival in the DOPPSAntonio Alberto Lopes, Jennifer L Bragg-Gresham, Sylvia P B Ramirez, et al.
Neurobiology of Aging|July 28, 2016
Longitudinal noninvasive magnetic resonance imaging of brain microhemorrhages in BACE inhibitor-treated APP transgenic miceNicolau Beckmann, Arno Doelemeyer, Stefan Zurbruegg, et al.
Clinical Kidney Journal|April 14, 2025
Increasing the adoption of home dialysis through improved advanced kidney care patient education: a call for actionUlrika Hahn Lundström, Gert Meeus, Tommy Aronsen, et al.
Diabetes Care|August 23, 2012
Hemoglobin A(1c) levels and mortality in the diabetic hemodialysis population: findings from the Dialysis Outcomes and Practice Patterns Study (DOPPS)Sylvia Paz B Ramirez, Keith P McCullough, Jyothi R Thumma, et al.
British Journal of Pharmacology|August 9, 2023
Orexin 2 receptor antagonism sex-dependently improves sleep/wakefulness and cognitive performance in tau transgenic miceRyan J Keenan, Heather Daykin, Jeremy Metha, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|August 28, 2018
Missed Hemodialysis Treatments: International Variation, Predictors, and Outcomes in the Dialysis Outcomes and Practice Patterns Study (DOPPS)Issa Al Salmi, Maria Larkina, Mia Wang, et al.
Research Square|February 27, 2026
Historic drought shifted fishing from a stigmatized practice and food to an adaptive livelihood among Daasanach pastoralists in northern KenyaKedir Teji Roba, Alfredo J Rojas, Matthew J Douglass, et al.
Pageof 61